OMED Shares Outstanding History



Below is a table of the OMED shares outstanding history going back to 7/17/2013:

Date OMED Shares Outstanding
7/17/201326.26M
8/23/201327.83M
10/31/201327.90M
3/11/201429.48M
5/1/201429.56M
7/31/201429.76M
10/30/201429.83M
3/6/201529.94M
5/1/201530.02M
8/4/201530.06M
11/2/201530.11M
3/7/201630.28M
5/2/201630.30M
8/1/201630.67M
10/28/201637.09M
3/6/201737.40M
5/5/201737.62M
8/1/201737.63M
10/31/201737.86M
3/7/201838.26M
5/7/201838.43M
8/1/201838.50M
10/31/201838.63M
3/5/201938.69M

Also see: OMED Market Cap History
OMED YTD Return
OMED Historical Shares Outstanding:
+7.12% CAGR
OMED Historical Shares Outstanding: +7.12% CAGR

Mouse over chart for data details
7/17/2013 ...3/5/2019
OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. has four anti-cancer therapeutic candidates: Navicixizumab, which is a bispecific monoclonal antibody that targets and inhibits both Delta-like ligand 4, and vascular endothelial growth factor; Anti-TIGIT, which is an inhibitory receptor that stops T-cells from attacking certain tumor cells; GITRL-Fc, which is engineered using a single-gene, linkerless trimer technology that is designed to enable activation of glucocorticoid-induced tumor necrosis factor receptor-related protein; and Rosmantuzumab, which is a monoclonal antibody targeting the RSPO-LGR cancer stem cell pathway. We show 24 historical shares outstanding datapoints in our coverage of OMED's shares outstanding history.

Understanding the changing numbers of OMED shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OMED versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OMED by allowing them to research OMED shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree OMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
OncoMed Pharmaceuticals (OMED) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

OMER Shares Outstanding History
OMGA Shares Outstanding History
OMI Shares Outstanding History
OMIC Shares Outstanding History
ONCE Shares Outstanding History
ONCO Shares Outstanding History
ONCR Shares Outstanding History
ONCS Shares Outstanding History
ONCT Shares Outstanding History
ONCY Shares Outstanding History
More Healthcare companies »

 

OMED Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.